Home

Medicus Pharma Ltd. - Common Stock (MDCX)

2.6350
-0.1550 (-5.56%)
NASDAQ · Last Trade: Jun 13th, 10:43 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Which stocks are experiencing notable movement on Friday?chartmill.com
Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · May 30, 2025
Top movers in Friday's sessionchartmill.com
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · May 30, 2025
Nasdaq Down 100 Points; Chicago PMI Dips In Maybenzinga.com
Via Benzinga · May 30, 2025
Traders are paying attention to the gapping stocks in Friday's session.chartmill.com
Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · May 30, 2025
Top movers in Friday's pre-market sessionchartmill.com
The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · May 30, 2025
Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · May 30, 2025
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.chartmill.com
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.
Via Chartmill · May 28, 2025
Top movers analysis in the middle of the day on 2025-05-28: top gainers and losers in today's session.chartmill.com
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · May 28, 2025
Medicus Pharma's 'Savvy' Antev Deal De-Risks Pipeline Expansion, Enhances Near-Commercial Portfoliobenzinga.com
Medicus to acquire Antev and expand into urology with Teverelix while reporting positive data in its Phase 2 skin cancer trial for D-MNA.
Via Benzinga · May 12, 2025
Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Mondaybenzinga.com
Via Benzinga · May 12, 2025
This Millrose Properties Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Mondaybenzinga.com
Via Benzinga · April 14, 2025